Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
A 13 years old male patient received an expired dose of Menveo (1 vial); This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 13-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 10-JUL-2025, the patient received Menveo. On 10-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: A 13 years old male patient received an expired dose of Menveo (1 vial)). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 15-JUL-2025 The reporter called to report the administration of an expired dose of Menveo (1 vial) to patient, which led expired vaccine used. The reporter asked what was the safety information, would the patient need another dose. Health care professional mentioned they called the parents of the patient and would repeat the dose at the time of reporting. The reporter consented to follow up.